Skip to content
AnalystLens

EQT 8-K Report, Regulation FD Disclosure (Mar 24, 2025)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed March 24, 2025
Period End
March 24, 2025
Security
EQT
In the record · 2016–202610-K1210-Q348-K232

EQT filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 232 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Mar ’18Mar ’18
  2. Leadership change8-K · May ’20May ’20
  3. Material agreement8-K · Nov ’22Nov ’22
  4. Material agreement8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed March 24, 2025. Cited figures are marked; the original filing is the authoritative source.

EQT Corporation issued a March 24, 2025 news release, furnished under Item 7.01 of Form 8-K, announcing two changes to its previously announced exchange offers and consent solicitations for notes issued by its indirect subsidiary EQM Midstream Partners, LP.

The expiration date for the Exchange Offers and Consent Solicitations was extended from 5:00 p.m. NYC time on March 24, 2025 to 5:00 p.m. NYC time on March 28, 2025, and the settlement date is now expected to be April 2, 2025.

EQT also waived the Consent Threshold Condition, which had required EQM to receive the requisite consents for all Existing EQM Notes. The condition was not met for the 5.500% Senior Notes due 2028, so the waiver allows the exchange to proceed despite that series falling short. The exchange program is sizable, with up to $4,541,839,000a in aggregate principal of new EQT notes available in exchange for the existing EQM notes, plus cash.

As of the March 7, 2025 Early Tender Date, tender levels were high across most series: roughly 97%b to 99% for the 7.500% 2027, 4.50% 2029, 6.375% 2029, 7.500% 2030, 4.75% 2031 and 7.500% 2027 notes, with 38% to 39% tendered for the 6.500% 2027 and 5.500% 2028 series. Consent solicitations seek amendments that would eliminate substantially all restrictive covenants and certain events of default in the EQM indentures. Withdrawal rights expired March 7, 2025 and were not extended.

For investors, the filing is primarily a balance sheet and capital structure update rather than an operational one. It shows strong holder participation in EQT's effort to consolidate and simplify the debt of its midstream subsidiary, which is important for creditors.

The filing does not disclose new financial results, guidance, or changes to operations. The low take-up on the 6.500%c 2027 and 5.500% 2028 notes, along with the waiver, are the main points to monitor.

02—Key points

Key Highlights

  1. Expiration date of the Exchange Offers and Consent Solicitations extended from March 24, 2025 to 5:00 p.m. NYC time on March 28, 2025; withdrawal rights expired March 7, 2025 and were not extended.
  2. EQT waived the Consent Threshold Condition, which had required consents for all Existing EQM Notes; the 5.500% Senior Notes due 2028 did not reach the requisite consents by the Early Tender Date.
  3. Up to $4,541,839,000 aggregate principal of new EQT notes, plus cash, offered in exchange for outstanding EQM notes.
  4. Strong participation in most series: 99.2% of the 7.500% 2027 notes, 98.9% of the 4.50% 2029 notes, 99.4% of the 6.375% 2029 notes, 98.8% of the 4.75% 2031 notes tendered at the Early Tender Date.
  5. Low participation in two series: 38.3% of the 6.500% 2027 notes (94.6% combined including a concurrent EQM tender offer) and 38.1% of the 5.500% 2028 notes.
  6. Proposed amendments would eliminate substantially all restrictive covenants, certain events of default and other provisions in the existing EQM indentures.
  7. Settlement is expected April 2, 2025, the third business day after the Expiration Date; TD Securities and J.P. Morgan are the lead dealer managers and solicitation agents.

03—Questions

Frequently Asked Questions

  1. Why did EQT extend the expiration date of the exchange offers?

    The filing does not state a specific reason. It only says the expiration date was moved from March 24, 2025 to March 28, 2025 at 5:00 p.m. NYC time, and that this date may be further extended.

  2. What does waiving the Consent Threshold Condition mean?

    The exchange offers originally required EQM to receive enough consents to adopt the proposed amendments for all Existing EQM Notes. Consents for the 5.500% Senior Notes due 2028 fell short, so EQT waived that requirement, allowing the exchange to proceed regardless of that series' consent shortfall.

  3. Which EQM notes had the strongest and weakest participation?

    Most series had about 97% to 99% of principal tendered at the Early Tender Date, including the 7.500% 2027, 4.50% 2029, 6.375% 2029, 7.500% 2030 and 4.75% 2031 notes. The weakest were the 6.500% 2027 notes (38.3%, or 94.6% including a concurrent EQM tender offer) and the 5.500% 2028 notes (38.1%).

  4. What would holders receive in the exchange?

    Eligible holders who validly tender their EQM notes would receive new notes issued by EQT, along with cash. The offering is capped at up to $4,541,839,000 aggregate principal amount of new EQT notes. Eligibility is limited to qualified institutional buyers under Rule 144A or non-U.S. persons under Regulation S.

  5. When will the exchange settle and what changes for remaining noteholders?

    Settlement is currently expected on April 2, 2025, the third business day after the Expiration Date. If the proposed amendments are adopted, the existing EQM indentures would lose substantially all restrictive covenants and certain events of default, which would reduce protections for holders who do not participate.

04—Continue

← View all 8-K filings